Arrient Healthcare Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Glimpure MV 2mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults.
Tablet
Glimpure MV 2mg/500mg/0.2mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimpure MV 2mg/500mg/0.2mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimpure MV 2mg/500mg/0.2mg Tablet.
Glimpure MV 2mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimpure MV 2mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimpure MV 2mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Glimpure MV 2mg/500mg/0.2mg Tablet contains three active ingredients: Glimepiride, Metformin and Voglibose. This combination is used to treat type 2 diabetes mellitus (DM). It helps improve blood glucose levels in adults when combined with a healthy diet and exercise routine. Glimepiride increases insulin release from the pancreas. Metformin reduces glucose production by the liver and enhances insulin sensitivity. Voglibose inhibits alpha-glucosidase activity, lowering postprandial (after meals) blood glucose levels. This medication is not prescribed for type 1 DM.
Common side effects associated with Glimpure MV 2mg/500mg/0.2mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
This medication must not be used in individuals with known allergies to any components or excipients of this medicine, nor those with moderate to severe kidney disease or inflammatory bowel diseases (IBD), colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis.
No, combining Glimpure MV 2mg/500mg/0.2mg Tablet with alcohol may be unsafe as it could lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Glimpure MV 2mg/500mg/0.2mg Tablet can lead to hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It is more likely to occur when missing meals, consuming alcohol, exercising excessively, or taking other antidiabetic medications with it. Monitoring blood sugar levels regularly and keeping glucose tablets, honey, or fruit juice readily available are crucial.
Store this medicine in its original container, tightly sealed. Refer to the packaging for further storage instructions. Dispose of unused medication responsibly, ensuring it is not accessible to children or pets. Always follow proper disposal guidelines provided by your healthcare provider.